Philippe Pinton (P Pinton)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Machine Learning

Decision Making

Transcription Factor

Patients With Inflammatory Bowel Disease

Top Venues

Clinical and translational science

Annals of medicine

Diagnostics (Basel, Switzerland)

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Frank-Dietrich Wagner, Stefan Schreiber, Yu Bagger, Katharina Bruzelius, Ali Falahati, Ola Sternebring, Arjun Ravi, Philippe Pinton
Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials. Clinical and translational science 17 (5) (2024)
Philippe Pinton
Machine Learning for Predicting Biologic Agent Efficacy in Ulcerative Colitis: An Analysis for Generalizability and Combination with Computational Models. Diagnostics (Basel, Switzerland) 14 (13) (2024)
Philippe Pinton
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of medicine 55 (2) (2024)
Philippe Pinton
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of medicine 55 (2) (2024)
Philippe Pinton
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of medicine 55 (2) (2024)
Frank-Dietrich Wagner, Stefan Schreiber, Yu Bagger, Katharina Bruzelius, Ali Falahati, Ola Sternebring, Arjun Ravi, Philippe Pinton
Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials. Clinical and translational science 17 (5) (2024)
Philippe Pinton
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of medicine 55 (2) (2024)
Philippe Pinton
Machine Learning for Predicting Biologic Agent Efficacy in Ulcerative Colitis: An Analysis for Generalizability and Combination with Computational Models. Diagnostics (Basel, Switzerland) 14 (13) (2024)
Philippe Pinton
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of medicine 55 (2) (2024)
Frank-Dietrich Wagner, Stefan Schreiber, Yu Bagger, Katharina Bruzelius, Ali Falahati, Ola Sternebring, Arjun Ravi, Philippe Pinton
Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials. Clinical and translational science 17 (5) (2024)
Anette Gabrielsen, Lea Hedegaard Iversen, Jens Fedder, Tilde Veng Eskildsen, Anne Lis Englund, Stine Ravn Hansen, Philippe Pinton
Pre-Vitrification and Post-Warming Variables of Vitrified-Warmed Blastocysts That Are Predictable for Implantation. Journal of clinical medicine 12 (19) (2023)
Philippe Pinton
Crohn's disease and short bowel syndrome. Surgery today 52 (12) (2022)
Feng Shao, Yi Jiang, Sijia Ding, Per Larsson, Philippe Pinton, Daniël Martijn Jonker
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women. Clinical drug investigation (2022)
Philippe Pinton
Prediction of vedolizumab treatment outcomes by machine learning. Journal of biopharmaceutical statistics 32 (5) (2022)
Philippe Pinton
Computational models in inflammatory bowel disease. Clinical and translational science 15 (4) (2022)
Philippe Pinton
Combination of vedolizumab and immunomodulators in ulcerative colitis. Journal of gastroenterology and hepatology (2021)
Philippe Pinton
Predictive approaches in inflammatory bowel disease. Clinical and translational science (2021)